The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma
- PMID: 15674855
- DOI: 10.1002/cncr.20889
The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma
Comment on
-
The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma.Cancer. 2004 Aug 15;101(4):810-6. doi: 10.1002/cncr.20418. Cancer. 2004. PMID: 15305414
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
